首页> 美国卫生研究院文献>Gut Pathogens >Metagenomics: aid to combat antimicrobial resistance in diarrhea
【2h】

Metagenomics: aid to combat antimicrobial resistance in diarrhea

机译:元基因组学:有助于抵抗腹泻中的抗菌素耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antimicrobial resistance (AMR) has emerged as an obstacle in the supple administration of antimicrobial agents to critical diarrheal patients. Most diarrheal pathogens have developed resistance against the major classes of antibiotics commonly used for assuaging diarrheal symptoms. Antimicrobial resistance develops when pathogens acquire antimicrobial resistance genes (ARGs) through genetic recombination from commensals and pathogens. These are the constituents of the complex microbiota in all ecological niches. The recombination events may occur in the environment or in the gut. Containment of AMR can be achieved through a complete understanding of the complex and diverse structure and function of the microbiota. Its taxonomic entities serve as focal points for the dissemination of antimicrobial resistance genetic determinants. Molecular methods complemented with culture-based diagnostics have been historically implemented to document these natural events. However, the advent of next-generation sequencing has revolutionized the field of molecular epidemiology. It has revolutionized the method of addressing relevant problems like diagnosis and surveillance of infectious diseases and the issue of antimicrobial resistance. Metagenomics is one such next-generation technique that has proved to be a monumental advancement in the area of molecular taxonomy. Current understanding of structure, function and dysbiosis of microbiota associated with antimicrobial resistance was realized due to its conception. This review describes the major milestones achieved due to the advent and implementation of this new technique in the context of antimicrobial resistance. These achievements span a wide panorama from the discovery of novel microorganisms to invention of translational value.
机译:抗菌药物耐药性(AMR)已成为向严重腹泻患者柔顺使用抗菌药物的障碍。大多数腹泻病原体对通常用于缓解腹泻症状的主要抗生素产生抗药性。当病原体通过共生和病原体的基因重组获得抗菌素耐药基因(ARG)时,就会产生抗菌素耐药性。这些是所有生态位中复杂微生物群的组成部分。重组事件可能发生在环境或肠道中。可以通过对微生物群复杂而多样的结构和功能的完全理解来实现对AMR的控制。它的生物分类实体是传播抗菌素耐药性遗传决定因素的重点。历史上已经实施了以基于文化的诊断方法为补充的分子方法来记录这些自然事件。但是,下一代测序技术的出现彻底改变了分子流行病学领域。它彻底改变了解决相关问题的方法,如传染病的诊断和监视以及抗菌素耐药性问题。元基因组学就是这样一种下一代技术,已被证明是分子分类学领域的巨大进步。由于其概念,人们对与抗菌素耐药性有关的微生物群的结构,功能和营养不良有了新的认识。这篇综述描述了在抗菌素耐药性方面由于这项新技术的出现和实施而取得的主要里程碑。这些成就涵盖了从发现新微生物到发明转化价值的广阔前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号